Detalles de la búsqueda
1.
The frequency of testing for glycated haemoglobin, HbA1c, is linked to the probability of achieving target levels in patients with suboptimally controlled diabetes mellitus.
Clin Chem Lab Med
; 57(2): 296-304, 2018 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30281512
2.
Inappropriate requesting of glycated hemoglobin (Hb A1c) is widespread: assessment of prevalence, impact of national guidance, and practice-to-practice variability.
Clin Chem
; 58(5): 906-15, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22344287
3.
Variability in Test Interval Is Linked to Glycated Haemoglobin (HbA1c) Trajectory over Time.
J Diabetes Res
; 2022: 7093707, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35615258
4.
Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes.
BMJ Open Diabetes Res Care
; 7(1): e000700, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31908789
5.
Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set.
Trials
; 19(1): 427, 2018 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30086771
6.
Reduced testing frequency for glycated hemoglobin, HbA1c, is associated with deteriorating diabetes control.
Diabetes Care
; 37(10): 2731-7, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25249670
Resultados
1 -
6
de 6
1
Próxima >
>>